Health Condition 1: L408- Other psoriasis
Conditions
Interventions
Intervention1: Marhame Asfadej and Joshanda Haleela Siyah: Joshanda Haleela Siyah 10 gm orally once daily before meal and
Marhame Asfadej 5gm local application twice a day
Control Intervention1: Mar
Sponsors
Rajiv Gandhi University Of Health Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Patient with m-PPPASI (Modified Palmoplantar Psoriasis Area Severity Index ) score up to moderate or 10-30% area involved at baseline Patients must be able and willing to provide written informed consent and comply with the requirements of this study protocol
Exclusion criteria
Exclusion criteria: Patient taking treatment of psoriasis including PUVA therapy, systemic steroids or systemic immunosuppressantâ??s for the last one month and above. Patient with erythrodermic psoriasis, generalized or localized pustular psoriasis. Pregnant and lactating mothers. Patients with Systemic disease Patients suffering from other concomitant skin diseases like Vitiligo, Eczema, and Lichen Simplex & Seborrheic Dermatitis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in m-PPPASI (Modified Palmoplantar Psoriasis Area Severity Index ) score Improvement in Modified Nail area psoriasis severity index Impovement in Physician global assessment scoreTimepoint: 42 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in Dermatological Life Quality Index (DLQI) Assessment by using PhotographTimepoint: 42 days | — |
Countries
India
Contacts
Public ContactDr Iram Naaz
National Institute of Unani Medicine
Outcome results
None listed